Literature DB >> 7937746

Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences.

F D Bushman1.   

Abstract

Certain retrovirus and retrotransposons display strong biases in the selection of host DNA sites for integration. To probe the possibility that simple tethering of the retroelement integrase protein to a target DNA site is sufficient to direct integration, the activities of a hybrid composed of human immunodeficiency virus 1 integrase and lambda repressor were analyzed. In in vitro reactions containing several target DNAs, the lambda repressor-integrase hybrid was found to direct integration selectively to targets containing lambda operators. Addition of lambda repressor blocked selective integration, indicating that binding to the operators was required. The lambda repressor-integrase hybrid protein directed integration primarily to sites near the operators on the same face of the B-DNA helix, indicating that target DNA was probably captured by looping out the intervening sequences. Such hybrid integrase proteins may be useful for directing retroviral integration to specific sequences in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937746      PMCID: PMC44786          DOI: 10.1073/pnas.91.20.9233

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Nonrandom integration of retroviral DNA in vitro: effect of CpG methylation.

Authors:  Y Kitamura; Y M Lee; J M Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Ty3 integrates within the region of RNA polymerase III transcription initiation.

Authors:  D L Chalker; S B Sandmeyer
Journal:  Genes Dev       Date:  1992-01       Impact factor: 11.361

3.  Sequence requirements for coiled-coils: analysis with lambda repressor-GCN4 leucine zipper fusions.

Authors:  J C Hu; E K O'Shea; P S Kim; R T Sauer
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

4.  Highly preferred targets for retrovirus integration.

Authors:  C C Shih; J P Stoye; J M Coffin
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

Review 5.  How the lambda repressor and cro work.

Authors:  M Ptashne; A Jeffrey; A D Johnson; R Maurer; B J Meyer; C O Pabo; T M Roberts; R T Sauer
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

6.  Retroviral DNA integration directed by HIV integration protein in vitro.

Authors:  F D Bushman; T Fujiwara; R Craigie
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

7.  Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity.

Authors:  P A Sherman; J A Fyfe
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

8.  Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA.

Authors:  F D Bushman; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

9.  Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core.

Authors:  D Pruss; F D Bushman; A P Wolffe
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

10.  Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin.

Authors:  S Vijaya; D L Steffen; H L Robinson
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

View more
  45 in total

1.  Protein determinants of insertional specificity for the Drosophila gypsy retrovirus.

Authors:  M Labrador; V G Corces
Journal:  Genetics       Date:  2001-07       Impact factor: 4.562

2.  Integrase-lexA fusion proteins incorporated into human immunodeficiency virus type 1 that contains a catalytically inactive integrase gene are functional to mediate integration.

Authors:  M L Holmes-Son; S A Chow
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Controlling integration specificity of a yeast retrotransposon.

Authors:  Yunxia Zhu; Junbiao Dai; Peter G Fuerst; Daniel F Voytas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

Review 4.  Integration by design.

Authors:  Suzanne Sandmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

5.  Patterns of Hermes transposition in Drosophila melanogaster.

Authors:  N Guimond; D K Bideshi; A C Pinkerton; P W Atkinson; D A O'Brochta
Journal:  Mol Genet Genomics       Date:  2003-01-25       Impact factor: 3.291

6.  Retargeting sleeping beauty transposon insertions by engineered zinc finger DNA-binding domains.

Authors:  Katrin Voigt; Andreas Gogol-Döring; Csaba Miskey; Wei Chen; Toni Cathomen; Zsuzsanna Izsvák; Zoltán Ivics
Journal:  Mol Ther       Date:  2012-07-10       Impact factor: 11.454

7.  Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties.

Authors:  Kwang-il Lim; Ryan Klimczak; Julie H Yu; David V Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

8.  Impact of repetitive DNA on sex chromosome evolution in plants.

Authors:  Roman Hobza; Zdenek Kubat; Radim Cegan; Wojciech Jesionek; Boris Vyskot; Eduard Kejnovsky
Journal:  Chromosome Res       Date:  2015-09       Impact factor: 5.239

9.  Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins.

Authors:  Jennifer Puglia; Tan Wang; Christine Smith-Snyder; Marie Cote; Michael Scher; Joelle N Pelletier; Sinu John; Colleen B Jonsson; Monica J Roth
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

10.  High-resolution genome-wide mapping of transposon integration in mammals.

Authors:  Stephen R Yant; Xiaolin Wu; Yong Huang; Brian Garrison; Shawn M Burgess; Mark A Kay
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.